NYSE$IMAX

IMAX Corp · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Reported a significant decrease in revenue due to global pandemic and theater closures.

IMAX Corporation reported a challenging second quarter due to the global pandemic, with a 92% decrease in revenue compared to the previous year. However, the company has taken cost reduction measures and is seeing early signs of progress with theater reopenings in China and other parts of the world. IMAX has a strong balance sheet with $319 million in consolidated cash and has amended its credit agreement for increased financial flexibility.

  • 409 IMAX theaters reopened in China over the July 24th weekend, representing approximately 40% of the global network generating revenue.
  • IMAX has a strong balance sheet with $319 million in consolidated cash as of June 30, 2020.
  • Cost reduction measures reduced the Company’s average monthly cash burn to approximately $10 million.
  • IMAX signed agreements to add 29 theater systems, demonstrating continued global demand.

Headline financials

Total Revenue

$8.86M

Previous: $105M-91.6%
EPS (adj)

-$0.44

Previous: $0.32-237.5%
Capital Expenditures

-$594K

Previous: -$4.18M+85.8%
Free Cash Flow

-$26.6M

Previous: $7.22M-467.8%
Net Income

-$26M

Previous: $11.4M-327.8%
Operating Income

-$41.5M

Previous: $24.1M-272.6%
Gross Profit

-$7.69M

Previous: $59.6M-112.9%
Cash & Equivalents

$319M

Previous: $106M+199.7%
Total Assets

$1.06B

Previous: $876M+21.2%

Revenue & EPS history

IMAX · Revenue · Quarterly

$8.86M

Q2 2020-91.6%vs Q2 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

IMAX · $100M total across 2 segments · Q3 2023

  • Technology Products
    $56.2M
  • Content Solutions
    $44.2M

Forward guidance

IMAX is looking ahead to an exceptionally strong slate through 2021, as studios affirm their commitment to the theatrical release by rescheduling their key blockbuster titles.

Tailwinds

  • Studios affirm their commitment to the theatrical release.
  • Key blockbuster titles are being rescheduled.
  • Major global exhibitors continue to underscore the value of The IMAX Experience.
  • New agreements including a 10-theatre deal with Wanda Film in China.
  • A multinational 17-theatre deal with CGV.

Headwinds

  • The health and safety of audiences must be the priority as theaters reopen.
  • Supporting the work of local governments and partners to put public health first.
  • Second quarter 2020 revenue decreased 92% versus 2019 to $8.9 million due to the global pandemic.
  • Second quarter 2020 net (loss) attributable to common shareholders was ($26) million.
  • Non-GAAP adjusted EBITDA (loss) was ($18.5) million versus $41.4 million in the prior-year period

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+1.2%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+1.6%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+18.6%

Q3 2017

Best reaction

-22.4%

Q2 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.1%-4.0%+6.1%
Q4 2025+14.7%+12.8%+0.1%
Q3 2025+1.0%+2.2%+12.4%
Q1 2025-3.3%+1.2%+11.9%
Q4 2024-1.1%-3.0%-1.7%
Q3 2024+15.7%+15.2%+25.3%
Q2 2024+12.7%+15.8%+19.9%
Q1 2024-2.9%-9.3%-4.3%
Q4 2023+12.0%+7.7%+3.3%
Q3 2023-0.3%-0.4%-9.1%
Q2 2023+11.5%+8.9%+10.4%
Q1 2023+8.0%+4.6%-11.3%
Q4 2022+9.1%+8.9%+7.6%
Q3 2022-5.9%-2.4%+24.8%
Q2 2022-2.3%-2.5%-8.9%
Q1 2022+4.9%+9.4%+15.3%
Q4 2021+7.0%+4.7%-1.5%
Q3 2021-8.9%-4.7%-17.0%
Q2 2021-5.6%-7.6%-11.6%
Q1 2021-7.0%-4.5%-2.6%
Q4 2020+13.5%+6.9%-3.2%
Q3 2020-2.2%-1.2%+31.3%
Q2 2020-11.2%-10.7%+22.3%
Q1 2020-7.8%-7.8%+0.2%
Q4 2019+0.6%-3.0%-38.1%
Q3 2019+3.1%+3.3%+2.5%
Q2 2019+2.1%+0.0%-2.0%
Q1 2019-3.4%-2.5%-11.7%
Q4 2018+9.0%+10.5%+9.1%
Q3 2018-4.9%-5.8%-10.1%
Q2 2018-1.6%-5.8%+8.6%
Q1 2018-2.6%-1.9%-9.9%
Q4 2017-10.8%-11.4%-18.8%
Q3 2017+18.6%+15.5%+17.9%
Q2 2017-2.8%-1.4%-13.4%
Q1 2017-0.9%-3.3%-15.8%
Q4 2016+6.5%+5.2%+10.4%
Q3 2016+2.6%+1.1%+13.3%
Q2 2016+14.3%+9.9%-0.4%
Q1 2016-1.3%
Q4 2015-9.2%
Q3 2015+0.8%
Q2 2015-3.9%
Q1 2015+0.8%
Q4 2014+6.9%
Q3 2014+3.2%
Q2 2014+7.2%
Q1 2014-8.0%
Q4 2013+2.3%
Q3 2013+4.5%
Q2 2013+2.7%
Q1 2013-5.3%
Q4 2012+3.3%
Q3 2012+3.1%
Q2 2012-3.3%
Q1 2012-2.8%
Q4 2011-1.4%
Q4 2009-1.4%
Q3 2011+16.9%
Q3 2010+16.9%
Q2 2011-22.4%
Q2 2010-22.4%
Q4 2010+8.6%
Q1 2011+8.6%
Q1 2010-6.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro